The Unichema representative, who proposed the agreement to his colleagues, has explained to the Commission that the object - also indicated to the other parties - was to enable the participants to monitor possible major changes in their relative positions as a result of any unilateral capacity reduction by Unichema which would follow the acquisition of Unilever-Emery by Unichema.
It was also emphasized by him that any capacity reduction made by Unichema was not to be taken as a signal that Unichema intended to withdraw from the fatty acids market - this too was indicated to the other parties.